[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356047-105":59,"doc-detail-356047-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","blood-circulating-c228t-tert-gene-promoter-mutation-is-an-independent-factor-for-the-prognosis-of-hbv-related-hepatocellular-carcinoma","Blood circulating C228T TERT gene promoter mutation is an independent factor for the prognosis of HBV–related hepatocellular carcinoma","","Background Telomerase reverse transcriptase (TERT) promoter mutations are common noncoding genetic lesions across cancers, but the clinical and pathological significance of hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC) patients carrying these promoter mutations remains only partially defined. Methods A nested real-time PCR assay was optimized to detect the C228T TERT gene promoter mutation from plasma with a low detection limit, then applied to evaluate its association with patient clinical presentation. Results C228T appeared exclusively in the HCC group and correlated with adverse clinical features, disease stage, and shorter overall survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/blood-circulating-c228t-tert-gene-promoter-mutation-is-an-independent-factor-for-the-prognosis-of-hbv-related-hepatocellular-carcinoma/356047/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/blood-circulating-c228t-tert-gene-promoter-mutation-is-an-independent-factor-for-the-prognosis-of-hbv-related-hepatocellular-carcinoma/356047.png","ImageObject",300,407,{"name":92,"@type":93},"awa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research question of this study?","Question",{"text":112,"@type":113},"The study investigates whether the blood-circulating C228T mutation in the TERT promoter is associated with prognosis in HBV-related hepatocellular carcinoma patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the C228T mutation detected in the study?",{"text":117,"@type":113},"A nested real-time PCR assay was optimized to detect the C228T TERT promoter mutation from plasma samples, using a specified low detection limit.",{"name":119,"@type":110,"acceptedAnswer":120},"What results connect C228T with patient outcomes?",{"text":121,"@type":113},"C228T was detected only in the HCC group, showed higher mutation rates in patients with worse clinical and liver function features and advanced stages, and was associated with shorter overall survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356047,1790804805,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Quang Trung et al. BMC Cancer (2026) 26:942 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16271-0](https://doi.org/10.1186/s12885-026-16271-0)  \nRESEARCH Open Access  \nBlood circulating C228T TERT gene promoter mutation is an independent factor for the prognosis of HBV–related hepatocellular carcinoma  \nPham Quang Trung1,3†, Pham Chau2,3†, Duong Quang Huy2, Nghiem Xuan Hoan3, Julien Reboud4, Nguyen Linh Toan2,3, Le Huu Song3* and Ngo Tat Trung1,3*  \nAbstract  \nBackground Telomerase reverse transcriptase (TERT) promoter mutations are among the most common noncoding genetic lesions in various cancers, including hepatocellular carcinoma (HCC) . The clinical and pathological implications of hepatitis B virus (HBV)–related HCC patients carrying promoter mutations are only partially resolved. Methods A nested real–time PCR assay was optimized to detect C228T TERT gene promoter mutation (C228T) from plasma samples with a detection limit of 0 . 1% . The established assay was used to investigate the association of the C228T with the clinical presentation of HBV–related HCC patients.  \nResults The C228T was detected only in the HCC group (n = 40/159, 25 . 2%), not in the other control groups  \n(n = 0/160) . The mutation rate was significantly higher in HCC patients with low albumin concentration, increased direct bilirubin, abdominal lymphadenopathy, and portal vein thrombosis, compared with HCC patients without these factors (p \u003C 0. 05); the mutation rate also increased progressively with more advanced stages (p \u003C 0. 05) and was significantly associated with shorter overall survival (OS) .  \nConclusion The C228T is associated with advanced stages, poorer liver function, and shorter overall survival; hence, it could be used as a novel biomarker for the prognosis of HBV–related HCC patients.  \nKeywords Hepatocellular carcinoma, TERTC228T promoter mutation, HBV infection  \n†Pham Quang Trung and Pham Chau contributed equally to this work.  \n*Correspondence: Le Huu Song [lehuusong@108-icid.com](lehuusong@108-icid.com)[ ](lehuusong@108-icid.com)Ngo Tat Trung [tatrungngo@gmail.com](tatrungngo@gmail.com)  \n1Department of Molecular Biology, 108 Military Central Hospital, No 1, Tran Hung Dao Street, Hai BaTrung Dist, Hanoi 10000, Vietnam 2Vietnam Military Medical University, Hanoi 10000, Vietnam 3Vietnamese–German Center for Medical Research, 108 Military Central Hospital, No 1, Tran Hung Dao Street, Hai BaTrung Dist, Hanoi  \n10000, Vietnam  \n4James Watt School of Engineering, University of Glasgow,  \nGlasgow G12 8QQ, UK  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nQuang Trung et al. BMC Cancer (2026) 26:942  \nIntroduction  \nHepatocellular carcinoma (HCC) is the sixth most frequent malignancy and the fourth leading cause of cancer–related death worldwide [1, 2] but the incidence rate is extremely high in Eastern Asia, including Vietnam [1]. According to Globoca","cbCairQrXFZ79rxj","https://ap.wps.com/l/cbCairQrXFZ79rxj","pdf",1703762,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main research question of this study?\",\"answer\":\"The study investigates whether the blood-circulating C228T mutation in the TERT promoter is associated with prognosis in HBV-related hepatocellular carcinoma patients.\"},{\"question\":\"How was the C228T mutation detected in the study?\",\"answer\":\"A nested real-time PCR assay was optimized to detect the C228T TERT promoter mutation from plasma samples, using a specified low detection limit.\"},{\"question\":\"What results connect C228T with patient outcomes?\",\"answer\":\"C228T was detected only in the HCC group, showed higher mutation rates in patients with worse clinical and liver function features and advanced stages, and was associated with shorter overall survival.\"}]","Blood circulating C228T TERT gene promoter mutation is an independent factor for the prognosis of HBV–related hepatocellular carcinoma | PDF",1790122976,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc833fd419bbb0052d80c14bc901493e.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eec92d92e0551c4e6bbe2ea9bc2422e3.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83f0006622d43387e3b72dbdff2273b1.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/571cbdf4e4e5b03a9ea386983014d552.webp",980,1306]